We are currently still particularly interested to hear stories from anyone who has experienced difficulties accessing the specialist thyroid drug, liothyronine / T3.

We are still pleased to hear from any further patients who would like to be available for media interviews following the release of the Liothyronine Case Evidence Dossier produced for Lord O'Shaughnessy.

We know that some patients who were stable on this medicine for a number of years have had it withdrawn because of the cost, putting them in crisis. While many of these patients have had their medication reinstated, many are still being refused it. 

If this is you - please tell us - or one of the other thyroid patient organisations. We are working hard to resolve the situation. 

We are also interested in any other stories you would like to share - read more about why we are collecting thyroid patient stories here.  

Your Privacy is important to us. See link at the bottom of this page to view our Privacy Policy